Skip to main content

Table 2 Background of colorectal cancer patients with serum TFF3 analysis

From: Serum TFF3 may be a pharamcodynamic marker of responses to chemotherapy in gastrointestinal cancers

Item

Cases (n)

Serum TFF3 (ng/ml)

P-value

Age

Ā Ā Ā 

ā€ƒā‰¤60

70

13.09ā€‰Ā±ā€‰0.95

0.0061

ā€ƒ>60

58

19.20ā€‰Ā±ā€‰2.11

Ā 

Gender

Ā Ā Ā 

ā€ƒMale

75

16.14ā€‰Ā±ā€‰1.42

0.7699

ā€ƒFemale

53

15.47ā€‰Ā±ā€‰1.82

Ā 

Site

Ā Ā Ā 

ā€ƒColon

67

15.86ā€‰Ā±ā€‰1.57

0.9957

ā€ƒRectum

61

15.47ā€‰Ā±ā€‰1.82

Ā 

Degree of differentiation

Ā Ā Ā 

ā€ƒWell-moderately

107

20.66ā€‰Ā±ā€‰3.74

0.057

ā€ƒPoorly

21

14.92ā€‰Ā±ā€‰1.11

Ā 

Stage

Ā 

(I-III VS IV)

0.0007

ā€ƒI

11

11.32ā€‰Ā±ā€‰2.21

Ā 

ā€ƒII

30

12.20ā€‰Ā±ā€‰0.88

Ā 

ā€ƒIII

25

14.27ā€‰Ā±ā€‰2.89

Ā 

ā€ƒIV

45

21.82ā€‰Ā±ā€‰2.39

Ā 

Lymphatic metastasis

Ā Ā Ā 

ā€ƒN(-)

46

11.86ā€‰Ā±ā€‰0.79

0.1786

ā€ƒN(+)

33

14.70ā€‰Ā±ā€‰2.22

Ā 

ā€ƒā€ƒN1

19

10.45ā€‰Ā±ā€‰1.09

0.00229

ā€ƒā€ƒN2

14

20.47ā€‰Ā±ā€‰1.98

Ā 

Distant metastasis

Ā Ā Ā 

ā€ƒM0

84

12.86ā€‰Ā±ā€‰0.99

0.001

ā€ƒM1

44

21.59ā€‰Ā±ā€‰2.44

Ā